ETF Managers Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,927
| Closed | -$363K | – | 759 |
|
|
2022
Q4 | $363K | Sell |
10,927
-1,983
| -15% | -$65.9K | 0.02% | 406 |
|
|
2022
Q3 | $407K | Sell |
12,910
-857
| -6% | -$27K | 0.01% | 502 |
|
|
2022
Q2 | $434K | Buy |
13,767
+560
| +4% | +$17.7K | 0.01% | 534 |
|
|
2022
Q1 | $348K | Buy |
13,207
+101
| +0.8% | +$2.66K | 0.01% | 522 |
|
|
2021
Q4 | $264K | Sell |
13,106
-2,724
| -17% | -$54.9K | 0.01% | 601 |
|
|
2021
Q3 | $308K | Buy |
15,830
+3,050
| +24% | +$59.3K | 0.01% | 592 |
|
|
2021
Q2 | $288K | Sell |
12,780
-35,534
| -74% | -$801K | ﹤0.01% | 587 |
|
|
2021
Q1 | $1.24M | Buy |
48,314
+16,107
| +50% | +$415K | 0.02% | 251 |
|
|
2020
Q4 | $626K | Buy |
32,207
+8,192
| +34% | +$159K | 0.01% | 301 |
|
|
2020
Q3 | $414K | Buy |
24,015
+11,865
| +98% | +$205K | 0.01% | 348 |
|
|
2020
Q2 | $265K | Buy |
+12,150
| New | +$265K | 0.01% | 484 |
|